Breast Cancer Cell Density: Imaging assay of the density- and context-dependence of small molecule perturbagen response in breast cancer cell lines. Dataset 1 of 3: Cell count and normalized growth rate inhibition values. - Dataset (ID:20256)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Replicate | Seeding Density | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value |
|---|---|---|---|---|---|---|---|---|---|---|
| BT-20 | Erlotinib | 1 | uM | 9 | 2500.00 | 1434.95 | 3239.00 | 3816.00 | 0.8488 | 0.7806 |
| BT-20 | 17-AAG | 0.000302 | uM | 9 | 2500.00 | 1434.95 | 3964.00 | 3816.00 | 1.0388 | 1.0547 |
| BT-20 | Lapatinib | 3.1623 | uM | 9 | 2500.00 | 1434.95 | 2728.00 | 3816.00 | 0.7149 | 0.5766 |
| BT-20 | 17-AAG | 0.31623 | uM | 9 | 2500.00 | 1434.95 | 1074.00 | 3816.00 | 0.2815 | -0.1856 |
| BT-20 | 0 | uM | 9 | 2500.00 | 1434.95 | 3451.00 | 3816.00 | 0.9044 | 0.8625 | |
| BT-20 | 0 | uM | 9 | 2500.00 | 1434.95 | 3562.00 | 3816.00 | 0.9334 | 0.9047 | |
| BT-20 | Linsitinib | 1 | uM | 9 | 2500.00 | 1434.95 | 3622.00 | 3816.00 | 0.9492 | 0.9274 |
| BT-20 | Erlotinib | 0.31623 | uM | 9 | 2500.00 | 1434.95 | 3241.00 | 3816.00 | 0.8493 | 0.7814 |
| BT-20 | 0 | uM | 9 | 2500.00 | 1434.95 | 4032.00 | 3816.00 | 1.0566 | 1.0796 | |
| BT-20 | Linsitinib | 19.9526 | uM | 9 | 2500.00 | 1434.95 | 1936.00 | 3816.00 | 0.5073 | 0.2365 |
| BT-20 | Linsitinib | 0.0033113 | uM | 9 | 2500.00 | 1434.95 | 4302.00 | 3816.00 | 1.1274 | 1.1773 |
| BT-20 | Erlotinib | 10 | uM | 9 | 2500.00 | 1434.95 | 2187.00 | 3816.00 | 0.5731 | 0.3480 |
| BT-20 | Erlotinib | 3.1623 | uM | 9 | 2500.00 | 1434.95 | 3029.00 | 3816.00 | 0.7938 | 0.6980 |
| BT-20 | 17-AAG | 0.0031623 | uM | 9 | 2500.00 | 1434.95 | 3934.00 | 3816.00 | 1.0309 | 1.0436 |
| BT-20 | Erlotinib | 0.01 | uM | 9 | 2500.00 | 1434.95 | 4320.00 | 3816.00 | 1.1321 | 1.1838 |
| BT-20 | Linsitinib | 0.01 | uM | 9 | 2500.00 | 1434.95 | 4217.00 | 3816.00 | 1.1051 | 1.1468 |
| BT-20 | 17-AAG | 0.0001 | uM | 9 | 2500.00 | 1434.95 | 4151.00 | 3816.00 | 1.0878 | 1.1229 |
| BT-20 | 17-AAG | 0.01 | uM | 9 | 2500.00 | 1434.95 | 3079.00 | 3816.00 | 0.8069 | 0.7178 |
| BT-20 | Linsitinib | 10 | uM | 9 | 2500.00 | 1434.95 | 2933.00 | 3816.00 | 0.7686 | 0.6597 |
| BT-20 | 0 | uM | 9 | 2500.00 | 1434.95 | 4103.00 | 3816.00 | 1.0752 | 1.1055 | |
| BT-20 | Lapatinib | 1 | uM | 9 | 2500.00 | 1434.95 | 3414.00 | 3816.00 | 0.8947 | 0.8483 |
| BT-20 | Lapatinib | 10 | uM | 9 | 2500.00 | 1434.95 | 1413.00 | 3816.00 | 0.3703 | -0.0109 |
| BT-20 | Lapatinib | 0.0033113 | uM | 9 | 2500.00 | 1434.95 | 4108.00 | 3816.00 | 1.0765 | 1.1073 |
| BT-20 | Linsitinib | 0.1 | uM | 9 | 2500.00 | 1434.95 | 3894.00 | 3816.00 | 1.0204 | 1.0289 |
| BT-20 | Lapatinib | 0.031623 | uM | 9 | 2500.00 | 1434.95 | 3770.00 | 3816.00 | 0.9880 | 0.9829 |